Gerresheimer
XTRA:GXI Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
WA
Consensus Narrative from 16 Analysts
Expansion Into High-Margin Biologics And Devices Indicates Strong Future Prospects
Key Takeaways Strategic expansion into high-margin segments like drug delivery systems and ready-to-use vials could enhance revenue and EBITDA margins significantly. Bormioli Pharma acquisition aims to broaden high-value offerings and margin expansion, supporting strong future earnings growth.
View narrative€108.92
FV
25.4% undervalued intrinsic discount11.55%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
12 days ago author updated this narrative